PATENT CLAIM ANALYSIS

Application Number: 16024407
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["544", "330000"]

Abstract:
Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R 5 , R 6 , R 8 , R 9 , R 11 , X 1 , and X 2  are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.

Claim (Index 18):
The method of  claim 17 , wherein the proliferative disorder is cancer and is selected from adrenal, anal, aplastic anemia, bile duct, bladder, bone, brain, breast, cervical, central nervous system, colon, endometrial, esophagial, ewing family, ocular, gallbladder, gastrointestinal carcinoid, gastrointestinal stromal, Kaposi sarcoma, kidney, laryngeal, leukemia, liver, lung, lymphomas, malignant mesothelioma, multiple myeloma, myelodysplastic syndrome, nasal cavity and paranasal sinus, nasopharyngeal, neuroblastoma, oral cavity and oropharyngeal, osteosarcoma, ovarian, pancreatic, penile, pituitary, prostate, rectal, retinoblastoma, rhabdomyosarcoma, salivary, sarcoma, skin, small intestine, stomach, testicular, thymus, thyroid, uterine sarcoma, vaginal, and Wilms tumor cancers.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.52778
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15120470', '15518541', '15380836', '15304947', '15737535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973617905870589
- 35 USC 102 Novelty (BERT): 0.5312250673652258
- Combined Prediction Score: 0.7707481182648757
- Mean Citation Score: 317.320912
- Max Citation Score: 369.75244
- Similarity Product: 361.130180645628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test